Ferring Pharmaceuticals Inc.

Parsippany, NJ Wholesale tradeNAICS 424210

Self-funded health planPlan year 2025Renews January
956Participants-3% vs. prior year
$2.3MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#9 of 16Wholesale trade in NJBy participants

Overview

Ferring Pharmaceuticals Inc. sponsors a self-funded health plan that covered 956 participants in plan year 2025, down 3% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
956 · prior year 986
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Ferring Pharmaceuticals Inc. Employee Benefit Plan, plan 501 (956 participants)
Broker compensation
$78K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disabilityDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Delta Dental of New Jersey, Inc.Dental2,051$1.3M$26K
Life Insurance Company of North AmericaLife, Short-term disability, Long-term disability, Accidental Death and Dismemberment932$1.2M$10K
Metropolitan Life Insurance CompanyAccident, Critical Illness936$272K$39K
Aetna Life Insurance CompanyVision2,068$84K$4K
Health Advocate Solutions Inc.Employee Assistance Program966$18K—
National Union Fire Ins. Co. of Pittsburgh, PABusiness Travel Accident932$14K—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$2.3M/ year

Estimated prescription spend: 956 participants × $2,371 national average per member. Usually higher once dependents are counted.

$59K–$145K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$17K–$43K
Lower-cost therapeutic alternatives$25K–$53K
Generic pricing vs. actual cost$11K–$33K
PBM contract terms$6K–$17K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Ferring Pharmaceuticals Inc.
Sponsor EIN
54-1179881
Plan number
501
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 54-1179881 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Ferring Pharmaceuticals Inc. 401(k) Savings Plan
Type
401(k) plan
Participants
1,507

About this data

Source: Ferring Pharmaceuticals Inc.'s Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Ferring Pharmaceuticals Inc..

Request a correction · Methodology